NeuroBo Pharmaceuticals Inc. (NRBO): Price and Financial Metrics
NRBO Price/Volume Stats
| Current price | $2.40 | 52-week high | $6.75 |
| Prev. close | $2.45 | 52-week low | $2.08 |
| Day low | $2.30 | Volume | 21,900 |
| Day high | $2.50 | Avg. volume | 406,239 |
| 50-day MA | $2.85 | Dividend yield | N/A |
| 200-day MA | $3.86 | Market Cap | 20.68M |
NRBO Stock Price Chart Interactive Chart >
NeuroBo Pharmaceuticals Inc. (NRBO) Company Bio
NeuroBo Pharmaceuticals Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapies for the treatment of dyslipidemia. NeuroBo Pharmaceuticals conducts business in the United States.
NRBO Price Returns
| 1-mo | -16.67% |
| 3-mo | -29.41% |
| 6-mo | -41.89% |
| 1-year | -29.69% |
| 3-year | -99.36% |
| 5-year | -99.89% |
| YTD | -35.08% |
| 2023 | -35.60% |
| 2022 | -98.04% |
| 2021 | -76.76% |
| 2020 | -40.00% |
| 2019 | -56.79% |
Loading social stream, please wait...